A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia
Clinical trial NCT07251309 · RECRUITING
Trial details
- NCT number
- NCT07251309
- Sponsor
- Waterstone Pharmaceutical (Wuhan) Co., LTD.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-23
- Primary completion
- 2026-11-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.